Mineralys Therapeutics Inc.

MLYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.31

+$0.29 (+1.03%)

At close: Sep 21, 2026, 4:00 PM ET

$28.01

-$0.30 (-1.06%)

Pre-market: Sep 22, 2026, 4:10 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	21K	21K	15K	15K	n/a	n/a	8K	8K	8K	8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-21K	-21K	-15K	-15K	n/a	n/a	-8K	-8K	-8K	-8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-370.79M	-171.5M	-170.6M	-184.09M	-203.07M	-201.49M	-192.4M	-168.35M	-134.51M	-105.08M	-84.66M	-66.95M	-48.1M	-38.85M	-31.48M	-28.55M	-21.13M	-14.65M	-7.08M
Interest Income	21.19M	19.71M	15.95M	12.72M	12.3M	12.97M	14.59M	15.1M	14.84M	14.28M	12.76M	10.37M	7.6M	4.01M	1.68M	741K	n/a	n/a	n/a
Pretax Income	-349.58M	-151.78M	-154.65M	-171.36M	-190.77M	-188.51M	-177.81M	-153.25M	-119.67M	-90.8M	-71.9M	-56.58M	-40.5M	-34.84M	-29.8M	-27.81M	-21.13M	-14.65M	-7.08M
Net Income	-349.58M	-151.78M	-154.65M	-171.36M	-190.77M	-188.51M	-177.81M	-153.25M	-119.67M	-90.8M	-71.9M	-56.58M	-40.5M	-34.84M	-29.8M	-27.81M	-21.13M	-14.65M	-7.08M
Selling & General & Admin	69.2M	53M	38.6M	31.92M	28.36M	25.78M	23.81M	20.64M	18.3M	16.25M	14.3M	12.46M	10.05M	7.08M	5.23M	3.51M	2.14M	1.26M	467K
Research & Development	301.59M	118.5M	132.01M	152.18M	174.71M	175.71M	168.58M	147.7M	116.21M	88.82M	70.36M	54.49M	38.05M	31.77M	26.25M	25.05M	18.99M	13.39M	6.62M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	370.78M	171.48M	170.59M	184.08M	203.07M	201.49M	192.4M	168.34M	134.51M	105.07M	84.66M	66.95M	48.1M	38.85M	31.48M	28.55M	21.13M	14.65M	7.08M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-8K	-8K	-8K	-8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	370.79M	171.5M	170.6M	184.09M	203.07M	201.49M	192.4M	168.35M	134.51M	105.08M	84.66M	66.95M	48.1M	38.85M	31.48M	28.55M	21.13M	14.65M	7.08M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	84.73M	82.83M	80.55M	70.59M	65.45M	53.16M	49.96M	49.82M	49.36M	44.9M	40.09M	39.93M	39.76M	24.76M	5.21M	5.18M	5.14M	5.12M	5.06M
Shares Outstanding (Diluted)	84.73M	82.83M	80.55M	70.59M	65.45M	53.16M	49.96M	49.82M	49.36M	44.9M	40.09M	39.93M	39.75M	24.76M	5.21M	5.18M	5.15M	5.12M	5.06M
EPS (Basic)	-4.24	-2.05	-2.37	-2.95	-3.56	-3.73	-3.64	-3.27	-2.71	-2.19	-2	-3.13	-3.85	-4.80	-5.77	-5.43	-4.14	-2.88	-1.40
EPS (Diluted)	-4.24	-2.05	-2.37	-2.95	-3.56	-3.73	-3.64	-3.27	-2.71	-2.19	-2	-3.13	-3.85	-4.80	-5.77	-5.43	-4.14	-2.88	-1.40
EBITDA	-349.54M	-151.73M	-154.59M	-171.3M	-190.72M	-188.46M	-177.77M	-153.18M	-119.61M	-90.75M	-71.85M	-46.57M	-23.07M	-10.93M	1.68M	745K	n/a	n/a	n/a
EBIT	-349.58M	-151.78M	-154.65M	-171.36M	-190.77M	-188.51M	-177.81M	-153.25M	-119.67M	-90.8M	-71.9M	-56.58M	-40.5M	-34.84M	-29.8M	-27.81M	-21.13M	-14.65M	-7.08M
Depreciation & Amortization	39K	50K	59K	61K	57K	50K	43K	71.81K	60.81K	51.81K	43.81K	10.01M	17.43M	23.91M	31.48M	28.55M	21.13M	14.65M	7.08M